246 Shares in Teleflex Incorporated (NYSE:TFX) Purchased by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC purchased a new stake in Teleflex Incorporated (NYSE:TFX) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 246 shares of the medical technology company’s stock, valued at approximately $61,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Riverview Trust Co acquired a new stake in shares of Teleflex during the first quarter worth approximately $31,000. GAMMA Investing LLC grew its holdings in Teleflex by 131.1% during the 3rd quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock worth $42,000 after acquiring an additional 97 shares in the last quarter. Canada Pension Plan Investment Board bought a new stake in shares of Teleflex in the 2nd quarter worth about $42,000. Versant Capital Management Inc raised its stake in shares of Teleflex by 20,700.0% in the 2nd quarter. Versant Capital Management Inc now owns 208 shares of the medical technology company’s stock valued at $44,000 after purchasing an additional 207 shares in the last quarter. Finally, Blue Trust Inc. lifted its position in shares of Teleflex by 78.2% during the second quarter. Blue Trust Inc. now owns 212 shares of the medical technology company’s stock worth $48,000 after purchasing an additional 93 shares during the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Stock Up 0.5 %

Teleflex stock opened at $237.82 on Thursday. The firm’s 50 day moving average price is $241.19 and its two-hundred day moving average price is $223.48. Teleflex Incorporated has a twelve month low of $177.63 and a twelve month high of $257.85. The firm has a market cap of $11.20 billion, a PE ratio of 38.17, a P/E/G ratio of 2.18 and a beta of 1.16. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 2.58.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, August 1st. The medical technology company reported $3.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.33 by $0.09. The business had revenue of $749.70 million during the quarter, compared to the consensus estimate of $762.98 million. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. Teleflex’s quarterly revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.41 EPS. On average, research analysts predict that Teleflex Incorporated will post 13.97 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Thursday, August 15th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend was Thursday, August 15th. Teleflex’s payout ratio is 21.83%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. Stephens boosted their price objective on Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a report on Friday, August 2nd. Royal Bank of Canada boosted their price target on shares of Teleflex from $260.00 to $275.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Truist Financial increased their target price on shares of Teleflex from $247.00 to $255.00 and gave the company a “hold” rating in a research note on Monday, October 14th. Finally, Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and increased their target price for the company from $205.00 to $245.00 in a research note on Monday, July 1st. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $268.86.

Insider Transactions at Teleflex

In related news, Director Stuart A. Randle sold 2,674 shares of the stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $238.93, for a total transaction of $638,898.82. Following the completion of the sale, the director now owns 5,496 shares in the company, valued at $1,313,159.28. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.43% of the stock is owned by insiders.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.